NDC 71288-175 – Etoposide
Etoposide 20 mg/mL · Injection, Solution, Concentrate · Intravenous
Product NDC71288-175
Product details
- Brand name
- Etoposide
- Generic name
- Etoposide
- Labeler
- Meitheal Pharmaceuticals Inc.
- Dosage form
- Injection, Solution, Concentrate
- Route
- Intravenous
- Marketing category
- ANDA · ANDA074529
- Marketed since
- February 1, 2025
- Listing expires
- December 31, 2026
- Pharmacologic class
- Topoisomerase Inhibitor
Active ingredients
- Etoposide 20 mg/mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 71288-175-05 | 1 VIAL, MULTI-DOSE in 1 CARTON (71288-175-05) / 5 mL in 1 VIAL, MULTI-DOSE | Feb 1, 2025 |
Other Etoposide products
- 68001-681 Etoposide 20 mg/mL · Injection, Solution, Concentrate · BluePoint Laboratories
- 68001-682 Etoposide 20 mg/mL · Injection, Solution, Concentrate · BluePoint Laboratories
- 68001-683 Etoposide 20 mg/mL · Injection, Solution, Concentrate · BluePoint Laboratories
- 71288-176 Etoposide 20 mg/mL · Injection, Solution, Concentrate · Meitheal Pharmaceuticals Inc.
- 71288-177 Etoposide 20 mg/mL · Injection, Solution, Concentrate · Meitheal Pharmaceuticals Inc.
- 16729-114 Etoposide 20 mg/mL · Injection · Accord Healthcare Inc.
- 68001-265 Etoposide 20 mg/mL · Injection · BluePoint Laboratories
- 63323-104 Etoposide 20 mg/mL · Injection, Solution · Fresenius Kabi USA, LLC
- 0143-9376 Etoposide 20 mg/mL · Injection · Hikma Pharmaceuticals USA Inc.
- 0143-9510 Etoposide 20 mg/mL · Injection · Hikma Pharmaceuticals USA Inc.
- 0143-9511 Etoposide 20 mg/mL · Injection · Hikma Pharmaceuticals USA Inc.
- 0143-9512 Etoposide 20 mg/mL · Injection · Hikma Pharmaceuticals USA Inc.